🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03168L105
- Market Cap
- Large Cap
- IPO
- 5/7/2018 · $17.00/share
Business: Amneal Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business.
Notes: May 7, 2018 -- Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. today announced that they have completed their business combination to form Amneal Pharmaceuticals, Inc.
Company Contact
- CEO
- Chirag Patel
- CFO
- Tasos Konidaris
- Headquarters
- 400 Crossing Boulevard, Bridgewater, NJ 08807
- Phone
- 908-947-3120
- Investor Relations
- Anthony DiMeo · 215-558-4526 · anthony.dimeo@amneal.com